Aclaris Therapeutics Inc (NASDAQ:ACRS)
| 0.9017 BATS BZX Real-Time Price As of 2:11pm ET |  +0.029 / +3.32%Today’s Change | 0.59 Today|||52-Week Range 18.54 | -94.27% Year-to-Date |
Latest ACRS News | Press Releases
No recent news for Aclaris Therapeutics Inc.
Today’s Trading
| Previous close | 0.87 |
| Today’s open | 0.86 |
| Day’s range | 0.84 - 0.93 |
| Volume | 82,543 |
| Average volume (3 months) | 2,956,662 |
| Market cap | $59.4M |
Data as of 2:11pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +16.79% |
| Earnings growth (this year) | -34.22% |
| Earnings growth (next 5 years) | +38.60% |
| Revenue growth (last year) | +340.05% |
| P/E ratio | NM |
| Price/Sales | 34.52 |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CKPTCheckpoint Therapeut... | +0.10 | +3.77% |
| SCYXSCYNEXIS Inc | -0.00 | -0.30% |
| EYENEyenovia Inc | +0.03 | +2.14% |
| CLSDClearside Biomedical... | +0.03 | +2.46% |
Data as of 2:09pm ET, 12/01/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $29.8M |
| Annual profit (last year) | -$86.9M |
| Net profit margin | -292.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Wayne, Pennsylvania |
Forecasts
